title: Atopic dermatitis today.
abstract: This review focuses on recent literature regarding atopic dermatitis (AD). New insights in epidemiology, diagnostic criteria, quality of life measures, provocative factors, patophysiology and therapy will be highlighted. New diagnostic criteria for AD set by the UK working party allow easier epidemiologic studies to cope with this increasingly prevalent disease. Immunomodulating therapy with cyclosporine holds promise in the treatment of refractory AD.
authors.affiliation: Unitat d'Al-lèrgia, Hospital General de Manresa, Spain.
authors.forename: S
authors.initials: S
authors.lastname: Nevot
authors.forename: R
authors.initials: R
authors.lastname: Lleonart
authors.forename: R
authors.initials: R
authors.lastname: Casas
mesh_terms: D000293:Adolescent; D000485:Allergens / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use; D003876:Dermatitis, Atopic / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000473:pathology / Q000628:therapy; D005512:Food Hypersensitivity / Q000150:complications; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D011788:Quality of Life
chemical_list: D000485:Allergens; D007166:Immunosuppressive Agents; D016572:Cyclosporine